TAC1 and acute myeloid leukemia: As we proved that NKA inhibition causes MCL1 downregulation, we assessed whether the MCL1/BCL2L1 ratio predicted the AML blast response to UNBS1450, like the ATP1A1/BCL2L1 ratio.